While the roles and mechanisms of FOXO3A in the development and progression of breast cancer [45], colon cancer [46], pancreatic cancer [47], lung cancer [48], and oral squamous cell carcinoma [49] have been reported in detail, little is known about its molecular mechanisms in mediating the development and prognosis of ESCC. This evidence concerns the gene FOXO3 and pancreatic neoplasm.